The strong beat and raised guidance, combined with 28% orders growth and 111% FCF conversion, signal accelerating momentum. Monitor the Q3 earnings call for further guidance raises and M&A deployment commentary, as the balance sheet supports strategic acquisitions.
Price Chart
Executive Summary
AMETEK reported record Q2 2026 results with sales of $2.04B (+15% YoY) and adjusted EPS of $2.09 (+17% YoY), beating consensus estimates of $1.99. The company raised full-year adjusted EPS guidance to $8.20-$8.30 (from $7.94-$8.14), reflecting strong underlying performance and broad-based orders growth of 28%. This marks a second consecutive quarter of exceptional orders and margin expansion, reinforcing the durability of the AMETEK Growth Model.
Key Financial Metrics
Key Facts
- Record Q2 2026 sales of $2.04B, up 15% YoY
- Adjusted EPS of $2.09, up 17% YoY and 4.8% above consensus of $1.99
- Full-year 2026 adjusted EPS guidance raised to $8.20-$8.30 from $7.94-$8.14
- Q2 operating cash flow up 35% to $483.7M; free cash flow conversion of 111%
- Orders grew 28% in Q2, second consecutive quarter of exceptional growth
- EIG core margins up 40bps to 30.1%; EMG core margins up 290bps to 26.2%
- Record backlog and broad-based demand across semiconductor, aerospace, medtech, defense, and automation markets
Financial Impact
Record Q2 revenue of $2.04B and adjusted EPS of $2.09; full-year guidance raised by $0.26 at midpoint to $8.20-$8.30
Risk Factors
- Integration risks from recent acquisitions (Indicor bridge financing fees noted)
- Potential tariff and trade dispute impacts on international operations
- Supply chain disruptions and raw material price volatility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001037868-26-000173 |
| Document: ame-20260804.htm | 0001037868-26-000173 |
| Document: 0001037868-26-000173-index-headers.html | 0001037868-26-000173 |
| Document: 0001037868-26-000173-index.html | 0001037868-26-000173 |
| Document: 0001037868-26-000173.txt | 0001037868-26-000173 |
| 8-K Data (Synthetic) | 0001037868-26-000173 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 26, 2026 5w ago | 8-K | $243.67 $247.74 | ▲ +1.67% | ▲ +2.18% | $252.98 (+3.82%) |
Aug 26, 2026 5w ago | Press Release | $243.67 $247.74 | ▲ +1.67% | ▲ +2.18% | $252.98 (+3.82%) |
Aug 12, 2026 7w ago | Insider Cluster | $258.52 $234.24 | ▼ −9.39% | ▼ −7.49% | $252.98 (−2.14%) |
Aug 11, 2026 7w ago | 8-K | $256.30 $236.27 | ▼ −7.82% | ▼ −6.76% | $252.98 (−1.30%) |
Aug 7, 2026 8w ago | Press Release | $253.66 $237.72 | ▼ −6.28% | ▼ −5.89% | $252.98 (−0.27%) |
Aug 4, 2026 8w ago | 8-K | $254.05 $231.32 | ▼ −8.95% | ▼ −7.71% | $252.98 (−0.42%) |
Jul 24, 2026 10w ago | Institutional Cluster | $241.97 $239.55 | ▼ −1.00% | ▼ −4.63% | $252.98 (+4.55%) |
Jul 16, 2026 11w ago | Press Release | $237.30 $256.22 | ▲ +7.97% | ▲ +4.36% | $252.98 (+6.61%) |
Jun 15, 2026 15w ago | Court Ruling | $230.45 $232.10 | ▲ +0.72% | ▲ +1.47% | $252.98 (+9.78%) |
Jun 12, 2026 15w ago | 8-K | $227.12 $233.98 | ▲ +3.02% | ▲ +1.24% | $252.98 (+11.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access